​

Mural Oncology Ownership | Who Owns Mural Oncology?

OverviewRevenueFinancialsChart

Mural Oncology Ownership Summary

Mural Oncology is owned by 29.96% institutional investors, 13.41% insiders, and 56.64% retail investors. Orbimed advisors is the largest institutional shareholder, holding 3.41% of MURA shares.

MURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMural Oncology29.96%13.41%56.64%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors588.80K3.41%$1.22M
Newtyn management522.92K3.03%$1.08M
Omers administration511.00K2.96%$1.06M
Vanguard group454.71K2.63%$941.25K
Rangeley capital305.00K1.77%$631.35K
Blackrock funding, inc. /de287.58K1.67%$595.29K
Rbf capital283.91K1.64%$587.70K
Deltec asset management179.06K1.04%$370.65K
Geode capital management175.11K1.01%$362.58K
Millennium management169.00K1.00%$212.94K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rangeley capital305.00K0.55%$631.35K
Newtyn management522.92K0.13%$1.08M
Yakira capital management163.95K0.12%$339.38K
Bml capital management57.50K0.11%$119.03K
Deltec asset management179.06K0.06%$370.65K
Torno capital170.00K0.03%$351.90K
Penderfund capital management82.80K0.03%$171.40K
Orbimed advisors588.80K0.03%$1.22M
Rbf capital283.91K0.03%$587.70K
Shay capital45.09K0.01%$93.33K

Top Buyers

HolderShares% AssetsChange
Omers administration511.00K0.01%511.00K
Rangeley capital305.00K0.55%258.49K
Deltec asset management179.06K0.06%179.06K
Torno capital170.00K0.03%170.00K
Yakira capital management163.95K0.12%163.95K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.72M
Soleus capital management---1.32M
Prosight management, lp---900.00K
Solas capital management---888.00K
Acorn capital advisors---653.78K

New Positions

HolderShares% AssetsChangeValue
Omers administration511.00K0.01%511.00K$1.06M
Deltec asset management179.06K0.06%179.06K$370.65K
Torno capital170.00K0.03%170.00K$351.90K
Yakira capital management163.95K0.12%163.95K$339.38K
Penderfund capital management82.80K0.03%82.80K$171.40K

Sold Out

HolderChange
Versant capital management-1.00
Cranbrook wealth management-4.00
Bell investment advisors-4.00
Ronald blue trust-6.00
Northwestern mutual wealth management-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202558-4.92%5,174,069-36.26%291.36%264.00%16-15.79%
Jun 30, 202566-1.49%8,234,676-1.91%471.99%2728.57%20-20.00%
Mar 31, 20254-94.59%2,749,454-70.69%160.54%1-96.15%3-86.96%
Dec 31, 2024745.71%9,381,197-1.48%541.76%2618.18%23-11.54%
Sep 30, 202470-14.63%9,521,654-12.63%551.35%22-31.25%26-16.13%

Recent Insider Transactions

DateNameRoleActivityValue
Nov 03, 2025Cutler Adam D. Chief Financial OfficerSell$14.94K
Nov 10, 2025Goodman Vicki L Chief Medical OfficerSell$10.47K
Jul 22, 2025Keson-Brookes Maiken See RemarksSell$6.38K
Jul 18, 2025Keson-Brookes Maiken See RemarksSell$5.35K
Jul 07, 2025Loew Caroline Chief Executive OfficerSell$30.48K

Insider Transactions Trends

DateBuySell
2025 Q4-2
2025 Q3-3
2025 Q2--
2025 Q1-4
2024 Q4-4

MURA Ownership FAQ

Who Owns Mural Oncology?

Mural Oncology shareholders are primarily institutional investors at 29.96%, followed by 13.41% insiders and 56.63% retail investors. The average institutional ownership in Mural Oncology's industry, Biotech Stocks , is 45.24%, which Mural Oncology falls below.

Who owns the most shares of Mural Oncology?

Mural Oncology’s largest shareholders are Orbimed advisors (588.8K shares, 3.41%), Newtyn management (522.92K shares, 3.03%), and Omers administration (511K shares, 2.96%). Together, they hold 9.40% of Mural Oncology’s total shares outstanding.

Does Blackrock own Mural Oncology?

BlackRock is not among the top 10 institutional shareholders of Mural Oncology.

Who is Mural Oncology’s biggest shareholder by percentage of total assets invested?

Rangeley capital is Mural Oncology’s biggest shareholder by percentage of total assets invested, with 0.55% of its assets in 305K Mural Oncology shares, valued at 631.35K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools